COLUMBIA, S.C., March 9 /PRNewswire/ -- Conformity markings allow Rhythmlink International products to be marketed throughout Europe, launching Rhythmlink to a new level within the neurodiagnostic and health care industry.
Effective immediately, Rhythmlink may sell and market product within the European Union [EU] and partnering nations. "Our ISO 13485:2003 certification is key to the growth of the company. This certification demonstrates to the markets in the European Union that Rhythmlink will provide products backed by a quality management system that reduces risk to patients," said Martin Barry, Rhythmlink International's regulatory affairs specialist.
Under European Directives and supported by European standards, Rhythmlink and its products are in full compliance with essential health and safety requirements. The CE Marking is Rhythmlink's declaration that all products meet the essential requirements of the European directives.
For more information about Rhythmlink's certifications, products and services, visit Rhythmlink.com.
Rhythmlink International, LLC
